Vadim A. Stepanov

Prof. Vadim A. Stepanov

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2007 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ETErika Tamm
Erika Tamm
TKToomas Kivisild
Toomas Kivisild
MRMaere Reidla
Maere Reidla
MMMait Metspalu
Mait Metspalu
DSDavid Glenn Smith
David Glenn Smith
RMRipan Malhi
Ripan Malhi
Native Americans derive from a small number of Asian founders who likely arrived to the Americas via Beringia. However, additional details about the intial colonization of the Americas remain unclear. To investigate the pioneering phase in the Americas we analyzed a total of 623 complete mtDNAs from the Americas and Asia, including 20 new complete mtDNAs from the Americas and seven from Asia. This sequence data was used to direct high-resolution genotyping from 20 American and 26 Asian populations. Here we describe more genetic diversity within the founder population than was previously reported. The newly resolved phylogenetic structure suggests that ancestors of Native Americans paused when they reached Beringia, during which time New World founder lineages differentiated from their Asian sister-clades. This pause in movement was followed by a swift migration southward that distributed the founder types all the way to South America. The data also suggest more recent bi-directional gene flow between Siberia and the North American Arctic.

1 February 2003 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
TKT. Kivisild
T. Kivisild
SRS. Rootsi
S. Rootsi
MMM. Metspalu
M. Metspalu
Sarabjit MastanaSarabjit Mastana
Sarabjit Mastana
KKK. Kaldma
K. Kaldma
RVR. Villems
R. Villems

28 April 2009 in Annals of Human Genetics
Verified
Journal Article
Open access
PDF file
HLHui Li
Hui Li
SBSvetlana Borinskaya
Svetlana Borinskaya
KYKimio Yoshimura
Kimio Yoshimura
NKNina Kal’iNa
Nina Kal’iNa
AMAndrey Marusin
Andrey Marusin
KKKenneth K. Kidd
Kenneth K. Kidd
Summary: Mitochondrial aldehyde dehydrogenase (ALDH2) is one of the most important enzymes in human alcohol metabolism. The oriental ALDH2*504Lys variant functions as a dominant negative, greatly reducing activity in heterozygotes and abolishing activity in homozygotes. This allele is associated with serious disorders such as alcohol liver disease, late onset Alzheimer disease, colorectal cancer, and esophageal cancer, and is best known for protection against alcoholism. Many hundreds of papers in various languages have been published on this variant, providing allele frequency data for many different populations. To develop a highly refined global geographic distribution of ALDH2*504Lys, we have collected new data on 4,091 individuals from 86 population samples and assembled published data on a total of 80,691 individuals from 366 population samples. The allele is essentially absent in all parts of the world except East Asia. The ALDH2*504Lys allele has its highest frequency in Southeast China, and occurs in most areas of China, Japan, Korea, Mongolia, and Indochina with frequencies gradually declining radially from Southeast China. As the indigenous populations in South China have much lower frequencies than the southern Han migrants from Central China, we conclude that ALDH2*504Lys was carried by Han Chinese as they spread throughout East Asia. Esophageal cancer, with its highest incidence in East Asia, may be associated with ALDH2*504Lys because of a toxic effect of increased acetaldehyde in the tissue where ingested ethanol has its highest concentration. While the distributions of esophageal cancer and ALDH2*504Lys do not precisely correlate, that does not disprove the hypothesis. In general the study of fine scale geographic distributions of ALDH2*504Lys and diseases may help in understanding the multiple relationships among genes, diseases, environments, and cultures.

14 July 2004 in Molecular Biology and Evolution
Verified
Journal Article
Closed access
PDF file
ELEva-Liis LoogvälI
Eva-Liis LoogvälI
URUrmas Roostalu
Urmas Roostalu
BMBoris Malyarchuk
Boris Malyarchuk
MDMiroslava V. Derenko
Miroslava V. Derenko
TKToomas Kivisild
Toomas Kivisild
RVRichard Villems
Richard Villems
It has been often stated that the overall pattern of human maternal lineages in Europe is largely uniform. Yet this uniformity may also result from an insufficient depth and width of the phylogenetic analysis, in particular of the predominant western Eurasian haplogroup (Hg) H that comprises nearly a half of the European mitochondrial DNA (mtDNA) pool. Making use of the coding sequence information from 267 mtDNA Hg H sequences, we have analyzed 830 mtDNA genomes, from 11 European, Near and Middle Eastern, Central Asian, and Altaian populations. In addition to the seven previously specified subhaplogroups, we define fifteen novel subclades of Hg H present in the extant human populations of western Eurasia. The refinement of the phylogenetic resolution has allowed us to resolve a large number of homoplasies in phylogenetic trees of Hg H based on the first hypervariable segment (HVS-I) of mtDNA. As many as 50 out of 125 polymorphic positions in HVS-I were found to be mutated in more than one subcluster of Hg H. The phylogeographic analysis revealed that sub-Hgs H1*, H1b, H1f, H2a, H3, H6a, H6b, and H8 demonstrate distinct phylogeographic patterns. The monophyletic subhaplogroups of Hg H provide means for further progress in the understanding of the (pre)historic movements of women in Eurasia and for the understanding of the present-day genetic diversity of western Eurasians in general.

1 November 2003 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
MRMaere Reidla
Maere Reidla
TKToomas Kivisild
Toomas Kivisild
EMEne Metspalu
Ene Metspalu
KKKatrin Kaldma
Katrin Kaldma
KTKristiina Tambets
Kristiina Tambets
RVRichard Villems
Richard Villems

15 June 2014 in Acta Naturae
Verified
Journal Article
Open access
PDF file
ETE A Trifonova
E A Trifonova
TGT V Gabidulina
T V Gabidulina
NEN I Ershov
N I Ershov
VSV N Serebrova
V N Serebrova
AVA Yu Vorozhishcheva
A Yu Vorozhishcheva
VSVadim A. Stepanov
Vadim A. Stepanov
Preeclampsia is one of the most severe gestational complications which is one of the leading causes of maternal and perinatal morbidity and mortality. A growth in the incidence of severe and combined forms of the pathology has been observed in recent years. According to modern concepts, inadequate cytotrophoblast invasion into the spiral arteries of the uterus and development of the ischemia-reperfusion syndrome in the placental tissue play the leading role in the development of preeclampsia, which is characterized by multipleorgan failure. In this regard, our work was aimed at studying the patterns of placental tissue transcriptome that are specific to females with PE and with physiological pregnancy, as well as identifying the potential promising biomarkers and molecular mechanisms of this pathology. We have identified 63 genes whose expression proved to differ significantly in the placental tissue of females with PE and with physiological pregnancy. A cluster of differentially expressed genes (DEG) whose expression level is increased in patients with preeclampsia includes not only the known candidate genes that have been identified in many other genome-wide studies (e.g., LEP, BHLHB2, SIGLEC6, RDH13, BCL6), but also new genes (ANKRD37, SYDE1, CYBA, ITGB2, etc.), which can be considered as new biological markers of preeclampsia and are of further interest. The results of a functional annotation of DEG show that the development of preeclampsia may be related to a stress response, immune processes, the regulation of cell-cell interactions, intracellular signaling cascades, etc. In addition, the features of the differential gene expression depending on preeclampsia severity were revealed. We have found evidence of the important role of the molecular mechanisms responsible for the failure of immunological tolerance and initiation of the pro-inflammatory cascade in the development of severe preeclampsia. The results obtained elaborate the concept of the pathophysiology of preeclampsia and contain the information necessary to work out measures for targeted therapy of this disease.